Change of Nerve Conduction Properties in IVIg Dependent Neuropathies [clinicaltrials:NCT01655394]
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies [clinicaltrials:NCT01655394]
Bio2RDF identifier
NCT01655394
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT01655394
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples Without DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
brief summary [clinicaltrials_vocabulary:brief-summary]
IVIg exert a variety of ...... europathies will be explored.
brief title [clinicaltrials_vocabulary:brief-title]
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2016-06-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
IVIg exert a variety of ...... neuropathies will be explored
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2012-07-30T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-12-11T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT01655394
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
org study id [clinicaltrials_vocabulary:org-study-id]
1.607.831.337
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2014-12-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2012-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-12-01T00:00:00Z
identifier
clinicaltrials:NCT01655394
title
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
@en
type
label
Change of Nerve Conduction Pro ...... s [clinicaltrials:NCT01655394]
@en